NASDAQ:OVAS - OvaScience Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
$14.69 +0.25 (+1.73 %)
(As of 03/24/2019 04:00 PM ET)
Previous Close$14.69
Today's Range$14.10 - $14.84
52-Week Range$0.66 - $1.52
Volume25,014 shs
Average Volume163,131 shs
Market Capitalization$526.34 million
P/E RatioN/A
Dividend YieldN/A
Beta3.11
OvaScience, Inc., a fertility company, discovers, develops, and commercializes fertility treatment options for women and families struggling with infertility worldwide. Its patented technology is based on the discovery about the existence of egg precursor (EggPC) cells to transform the treatment landscape for women's fertility. The company offers various fertility treatment options, including OvaPrime treatment to restore a woman's egg production by isolating a woman's own EggPC cells within her ovary to mature in vivo into healthy and fertilizable eggs; OvaTure treatment to mature EggPC cells into fertilizable eggs in vitro or outside the body by eliminating the need for hormone stimulation; and AUGMENT treatment to enhance the fertilization and pregnancy rates by using mitochondria from a woman's own EggPC cells. It also provides OvaXon for the prevention of inherited diseases for human and animal health. The company was formerly known as Ovastem, Inc. and changed its name to OvaScience, Inc. in May 2011. OvaScience, Inc. was founded in 2011 and is headquartered in Waltham, Massachusetts.

Receive OVAS News and Ratings via Email

Sign-up to receive the latest news and ratings for OVAS and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Pharmaceutical preparations
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:OVAS
CUSIPN/A
Phone617-500-2802

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$290,000.00
Book Value$1.80 per share

Profitability

Net Income$-50,970,000.00
Net Margins-10,128.37%

Miscellaneous

EmployeesN/A
Market Cap$526.34 million
Next Earnings DateN/A
OptionableOptionable

OvaScience (NASDAQ:OVAS) Frequently Asked Questions

What is OvaScience's stock symbol?

OvaScience trades on the NASDAQ under the ticker symbol "OVAS."

Has OvaScience been receiving favorable news coverage?

Headlines about OVAS stock have trended neutral this week, according to InfoTrie Sentiment Analysis. InfoTrie identifies positive and negative media coverage by monitoring more than six thousand blog and news sources in real-time. The firm ranks coverage of public companies on a scale of negative five to five, with scores closest to five being the most favorable. OvaScience earned a media sentiment score of 0.2 on InfoTrie's scale. They also assigned press coverage about the biotechnology company a news buzz of 3.0 out of 10, indicating that recent media coverage is unlikely to have an effect on the stock's share price in the near future.

Who are some of OvaScience's key competitors?

What other stocks do shareholders of OvaScience own?

Who are OvaScience's key executives?

OvaScience's management team includes the folowing people:
  • Dr. Christopher A. Kroeger M.D., MBA, CEO, Pres, Sec. & Director (Age 50)
  • Dr. Michelle Dipp, Co-Founder & Advisor (Age 42)
  • Mr. Jonathan Gillis, Sr. VP of Fin. & Treasurer (Age 37)
  • Dr. Jonathan L. Tilly Ph.D., Co-Founder and Advisor (Age 55)
  • Ms. Katherine Pare Lefeber, VP of Strategy & Operations

How do I buy shares of OvaScience?

Shares of OVAS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is OvaScience's stock price today?

One share of OVAS stock can currently be purchased for approximately $14.69.

How big of a company is OvaScience?

OvaScience has a market capitalization of $526.34 million and generates $290,000.00 in revenue each year.

What is OvaScience's official website?

The official website for OvaScience is http://www.ovascience.com.

How can I contact OvaScience?

OvaScience's mailing address is 9 FOURTH AVENUE, WALTHAM MA, 02451. The biotechnology company can be reached via phone at 617-500-2802 or via email at [email protected]


MarketBeat Community Rating for OvaScience (NASDAQ OVAS)

Community Ranking:  2.6 out of 5 (star star)
Outperform Votes:  258 (Vote Outperform)
Underperform Votes:  247 (Vote Underperform)
Total Votes:  505
MarketBeat's community ratings are surveys of what our community members think about OvaScience and other stocks. Vote "Outperform" if you believe OVAS will outperform the S&P 500 over the long term. Vote "Underperform" if you believe OVAS will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 3/24/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel